Skip to main content
Caplight Logo









Ozelle Diagnostics

Ozelle Diagnostics

Private
FrankfurtHealthcare & Life Scienceshttps://ozellemed.com/en/

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Ozelle Diagnostics is a medical technology company that develops AI-powered hematology and multi-functional diagnostic systems for human and veterinary applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

point-of-care diagnosticshematology analyzercomplete blood morphologyCBMmedical AIclinical diagnosticsveterinary diagnosticslab-on-a-chipPOC testingautomated cell imagingdiagnostic softwarebiotech equipmentpay-per-testdigital pathologyIoT medical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ozelle Diagnostics Comparables

Compare Ozelle Diagnostics with similar companies based on industry and business-model similarity.

Ozelle Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scopio Labs
84%
Sight Diagnostics
83%
Noul Co. Ltd.
79%

Ozelle Diagnostics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Grew 42% QoQ, from 48 to 68 employees.

  • Jul 18, 2026

    Grew 36% QoQ, from 44 to 60 employees.

Recent news

Latest coverage and updates

  • attends_eventJul 28, 2026

    Ozelle GmbH attended event ADLM 2026 on Jul 29th '26.

  • attends_eventJul 28, 2026

    Ozelle GmbH was planning to attend event ADLM 2026 on Jul 1st '26.

  • launchesJul 28, 2026

    Ozelle GmbH launched O-Cyte 1 at ADLM 2026 on Jul 29th '26.

Ozelle Diagnostics Filings

Explore SEC and related filing metadata, where available.

Ozelle Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ozelle Diagnostics's valuation, stock price, and market status.

Is Ozelle Diagnostics a public or private company?

Ozelle Diagnostics is a private company.

What is the current stock price of Ozelle Diagnostics?

Ozelle Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Ozelle Diagnostics worth (valuation)?

Valuation information for Ozelle Diagnostics is not publicly available.

Can I buy Ozelle Diagnostics stock?

Ozelle Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ozelle Diagnostics's last funding round?

Funding round information for Ozelle Diagnostics is not publicly available.

Who are the main investors in Ozelle Diagnostics?

Investor information for Ozelle Diagnostics is not publicly disclosed.

Will Ozelle Diagnostics IPO soon?

No public IPO plans have been announced for Ozelle Diagnostics.

How can I track Ozelle Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ozelle Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrankfurt
Employee Range68
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?